Clinical Trials Browser

Phase 1/2 × Pancreatic Diseases × sonidegib × Clear all

NCT01431794 2020-01-22

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Phase 1/2 Terminated

23 enrolled 10 charts

Gastrointestinal

Carcinoma, Pancreatic Diseases